FDA
approval
· 2020-03-06
FDA Approved: ISTURISA — Original Application (Recordati Rare Diseases, Inc.)
Summary
FDA approved ISTURISA (osilodostat) through an original NDA for adults with Cushing's disease. The approval provides a new treatment option for patients who can…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ISTURISA (OSILODROSTAT)